台股 » 個股 » 國邑* » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國邑*

(6875)
  • 股價
    57.6
  • 漲跌
    ▼1.6
  • 漲幅
    -2.70%
  • 成交量
    348
  • 產業
    上櫃 生技醫療類股
  • 8人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
國邑* (6875)籌碼相關-元大-城東 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-城東 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/20860.0000.0059.2082702.96%
2024/11/19860.0600.0060.7082692.96%
2024/11/18861.7100.0060.1082722.93%
2024/11/152962.96163.0062.202827310.24%
2024/11/1412763.7300.0063.0012728244.89% 大買/鉅額交易
2024/11/137563.6000.0063.207528226.58%
2024/11/127364.2800.0063.507328325.74%
2024/11/117864.9100.0064.507828427.46%
2024/11/084364.8200.0064.604328215.24%
2024/11/074561.9000.0062.904528016.02%
2024/11/064764.4000.0061.604728116.67%
2024/11/044462.9300.0061.904429315.01%
2024/11/011261.1000.0060.60122984.02%
2024/10/281662.5000.0061.60163135.11%
2024/10/25562.7400.0062.5053131.60%
2024/10/242464.5000.0063.90243147.64%
2024/10/23663.5000.0062.8063111.93%
2024/10/18362.7000.0062.0033220.93%
2024/10/17663.3000.0063.4063221.86%
2024/10/16263.1000.0063.2023240.62%
2024/10/14664.5000.0064.6063281.82%
2024/10/0700.00869.2068.00-8324-2.46%
2024/09/27362.2700.0063.0032911.03%
2024/09/19166.0000.0066.0012940.34%
2024/09/121564.70364.8064.20122944.07%
2024/09/054263.9300.0060.904228814.57%
2024/09/02564.6200.0066.0052891.73%
2024/08/29159.0000.0060.8012790.36%
2024/08/23165.0000.0061.5012740.36%
2024/08/07151.5000.0051.7012810.36%
2024/08/01258.0000.0058.3022690.74%
2024/07/31256.7000.0056.6022690.74%
2024/07/2900.001057.1457.10-10267-3.74%
2024/07/2600.00657.6059.50-6279-2.14%
2024/07/22163.00660.5060.80-5288-1.73%
2024/07/171267.0000.0067.10122894.14%
2024/07/12265.1500.0064.8023060.65%
2024/07/11265.3000.0065.2023090.65%
2024/07/09366.0000.0065.8033290.91%
2024/07/0800.001567.1667.20-15333-4.50%
2024/07/051268.9200.0068.00123363.57%
2024/07/03168.1000.0068.8013410.29%
2024/07/02168.0000.0069.3013440.29%
2024/07/01171.1000.0070.1013500.29%
2024/06/27172.0000.0074.0013800.26%
2024/06/24271.4500.0070.5024520.44%
2024/06/20470.9800.0071.2044580.87%
2024/06/12270.0000.0069.5024860.41%
2024/06/11270.4000.0070.0025000.40%
2024/06/05177.3000.0077.4015440.18%
2024/06/04177.7000.0076.6015550.18%
2024/06/03176.70276.8076.70-1582-0.17%
2024/05/3000.00177.5076.50-1623-0.16%
2024/05/29276.0000.0076.7026450.31%
2024/05/28176.5000.0076.3017010.14%
2024/05/21980.5000.0077.0098441.07%
2024/05/2000.001577.2082.00-15849-1.77%
2024/05/1700.002474.7875.90-24863-2.78%
2024/05/16572.0000.0071.5058920.56%
2024/05/151972.1200.0071.90199382.02%
2024/05/141871.6900.0073.00189591.88%
2024/05/1300.00171.4071.50-1959-0.10%
2024/05/0800.00168.0069.30-1971-0.10%
2024/04/3000.00173.0073.50-1961-0.10%
2024/04/2500.00166.5065.30-1932-0.11%
2024/04/23168.0000.0068.4019190.11%
2024/04/18169.5000.0069.0019090.11%
2024/04/17171.40472.0071.80-3906-0.33%
2024/04/0900.00180.3080.20-1863-0.12%
2024/04/0800.00381.4081.20-3858-0.35%
2024/04/0300.00182.9082.90-1853-0.12%
2024/04/02184.1000.0084.1018470.12%
2024/04/01183.4000.0086.9018350.12%
2024/03/29380.30180.0080.0028130.25%
2024/03/28386.9300.0083.1037870.38%
國邑*吸入新藥完成澳洲一期臨床 預計年底完成與美國FDA Pre-IND會議Anue鉅亨-28天前
國邑* 相關文章
國邑* 相關影音